Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-11

Clinical Trial Update: Using Flavonoids to Kill Hepatitis B Virus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating flavonoids as a potential treatment for Hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flavonoids

Snippet

Sponsor: Trieu, Nguyen Thi, M.D. | Conditions: Hepatitis B Virus Infection | Phase 4 | Status: COMPLETED